Comparison of the acute hematopoietic capacities of erythropoietin and U-74389G concerning hematocrit levels.

CONCLUSIONS: The anti-oxidant capacities of U-74389G provide satisfactory acute hematopoietic properties; presenting approximately 12.66-fold hematocrit level rise than epo (p-value=0.0000). PMID: 28155601 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28155601?dopt=Abstract

Source: Cardiovascular and Hematological Disorders Drug Targets - February 6, 2017 Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research